Abstract: The present disclosure provides adeno-associated virus (AAV) virions with altered capsid protein, where the AAV virions exhibit greater infectivity of retinal cells compared to wild-type AAV. The present disclosure further provides methods of delivering a gene product to a retinal cell in an individual, and methods of treating ocular disease.
Type:
Grant
Filed:
August 23, 2016
Date of Patent:
December 3, 2019
Assignee:
The Regents of the University of California
Inventors:
David V. Schaffer, Ryan R. Klimczak, James T. Koerber, John G. Flannery